Critical roles of chemokine receptor CCR5 in regulating glioblastoma proliferation and invasion

Acta Biochimica et Biophysica Sinica

Volumn 47, Issue 11, 2015, Pages 890-898

  Zhao, Lanfu ^a   Wang, Yuan ^a   Xue, Yafei ^a   Lv, Wenhai ^a   Zhang, Yufu ^a   He, Shiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Akt pathway; carcinogenesis; CCR5; glioblastoma; invasion

Indexed keywords

CCR5 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR5; RANTES;

ANIMAL; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL PROLIFERATION; GLIOBLASTOMA; HUMAN; METABOLISM; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; TUMOR CELL LINE; TUMOR INVASION; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CHEMOKINE CCL5; GLIOBLASTOMA; HETEROGRAFTS; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; PROGNOSIS; RECEPTORS, CCR5;

EID: 84947784819     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gmv095     Document Type: Article

References (52)

1. Dolecek TA, Propp JM, Stroup NE, Kruchko C. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. Neuro Oncol 2012, 14(Suppl 5): v1-49.
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005, 352: 987-996.
3. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ. Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 2010, 60: 166-193.
4. Chen L, Zhang A, Li Y, Zhang K, Han L, Du W, Yan W, et al. MiR-24 regulates the proliferation and invasion of glioma by ST7L via beta-catenin/Tcf-4 signaling. Cancer Lett 2013, 329: 174-180.
5. Chen L, Zhang W, Yan W, Han L, Zhang K, Shi Z, Zhang J, et al. The putative tumor suppressor miR-524-5p directly targets Jagged-1 and Hes-1 in glioma. Carcinogenesis 2012, 33: 2276-2282.
6. Bachelerie F, Graham GJ, Locati M, Mantovani A, Murphy PM, Nibbs R, Rot A, et al. New nomenclature for atypical chemokine receptors. Nat Immunol 2014, 15: 207-208.
7. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001, 22: 147-184.
8. Murphy PM. International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 2002, 54: 227-229.
9. Roussos ET, Condeelis JS, Patsialou A. Chemotaxis in cancer. Nat Rev Cancer 2011, 11: 573-587.
10. Balkwill FR. The chemokine system and cancer. J Pathol 2012, 226: 148-157.
11. Kulbe H, Levinson NR, Balkwill F, Wilson JL. The chemokine network in cancer - much more than directing cell movement. Int J Dev Biol 2004, 48: 489-496.
12. Li T, Li H, Wang Y, Harvard C, Tan JL, Au A, Xu Z, et al. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma. J Pathol 2011, 223: 519-530.
13. Ou DL, Chen CL, Lin SB, Hsu CH, Lin LI. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy. J Pathol 2006, 210: 363-373.
14. Ping YF, Yao XH, Jiang JY, Zhao LT, Yu SC, Jiang T, Lin MC, et al. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling. J Pathol 2011, 224: 344-354.
15. Hattermann K, Held-Feindt J, Ludwig A, Mentlein R. The CXCL16-CXCR6 chemokine axis in glial tumors. J Neuroimmunol 2013, 260: 47-54.
16. Munson JM, Bellamkonda RV, Swartz MA. Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism. Cancer Res 2013, 73: 1536-1546.
17. Choi YH, Burdick MD, Strieter BA, Mehrad B, Strieter RM. CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells. Mol Cancer Res 2014, 12: 38-47.
18. Deutsch AJ, Aigelsreiter A, Steinbauer E, Fruhwirth M, Kerl H, Beham-Schmid C, Schaider H, et al. Distinct signatures of B-cell homeostatic and activation-dependent chemokine receptors in the development and progression of extragastric MALT lymphomas. J Pathol 2008, 215: 431-444.
19. Bajetto A, Barbieri F, Dorcaratto A, Barbero S, Daga A, Porcile C, Ravetti JL, et al. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration. Neurochem Int 2006, 49: 423-432.
20. Bajetto A, Barbieri F, Pattarozzi A, Dorcaratto A, Porcile C, Ravetti JL, Zona G, et al. CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro Oncol 2007, 9: 3-11.
21. Lederman MM, Penn-Nicholson A, Cho M, Mosier D. Biology of CCR5 and its role in HIV infection and treatment. JAMA 2006, 296: 815-826.
22. Lim JK, Glass WG, McDermott DH, Murphy PM. CCR5: no longer a "good for nothing" gene - chemokine control of West Nile virus infection. Trends Immunol 2006, 27: 308-312.
23. Suzuki S, Miyagi T, Chuang LF, Yau PM, Doi RH, Chuang RY. Chemokine receptor CCR5: polymorphism at protein level. Biochem Biophys Res Commun 2002, 296: 477-483.
24. Aramori I, Ferguson SS, Bieniasz PD, Zhang J, Cullen B, Cullen MG. Molecular mechanism of desensitization of the chemokine receptor CCR-5: receptor signaling and internalization are dissociable from its role as an HIV-1 co-receptor. EMBO J 1997, 16: 4606-4616.
25. Zhao J, Ma L, Wu YL, Wang P, Hu W, Pei G. Chemokine receptor CCR5 functionally couples to inhibitory G proteins and undergoes desensitization. J Cell Biochem 1998, 71: 36-45.
26. Leach K, Charlton SJ, Strange PG. Analysis of second messenger pathways stimulated by different chemokines acting at the chemokine receptor CCR5. Biochem Pharmacol 2007, 74: 881-890.
27. Chen L, Han L, Zhang K, Shi Z, Zhang J, Zhang A, Wang Y, et al. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1alpha/VEGF and beta-catenin/Tcf-4 signaling. Neuro Oncol 2012, 14: 1026-1036.
28. Chen L, Zhang J, Feng Y, Li R, Sun X, Du W, Piao X, et al. MiR-410 regulates MET to influence the proliferation and invasion of glioma. Int J Biochem Cell Biol 2012, 44: 1711-1717.
29. Chen L, Liu X, Zhang HY, Du W, Qin Z, Yao Y, Mao Y, et al. Upregulation of chemokine receptor CCR10 is essential for glioma proliferation, invasion and patient survival. Oncotarget 2014, 5: 6576-6583.
30. Velasco-Velazquez M, Xolalpa W, Pestell RG. The potential to target CCL5/CCR5 in breast cancer. Expert Opin Ther Targets 2014, 18: 1265-1275.
31. Wang SW, Liu SC, Sun HL, Huang TY, Chan CH, Yang CY, Yeh HI, et al. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment. Carcinogenesis 2015, 36: 104-114.
32. Jacobs VL, Valdes PA, Hickey WF, De Leo JA. Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model. ASN Neuro 2011, 3: e00063.
33. Sun Z, Liu H, Yang Z, Shao D, Zhang W, Ren Y, Sun B, et al. Intestinal trefoil factor activates the PI3K/Akt signaling pathway to protect gastric mucosal epithelium from damage. Int J Oncol 2014, 45: 1123-1132.
34. Wu X, Chen Y, Li G, Xia L, Gu R, Wen X, Ming X, et al. Her3 is associated with poor survival of gastric adenocarcinoma: Her3 promotes proliferation, survival and migration of human gastric cancer mediated by PI3K/AKT signaling pathway. Med Oncol 2014, 31: 903.
35. Bedal KB, Grassel S, Oefner PJ, Reinders J, Reichert TE, Bauer R. Collagen XVI induces expression of MMP9 via modulation of AP-1 transcription factors and facilitates invasion of oral squamous cell carcinoma. PLoS ONE 2014, 9: e86777.
36. Dilly AK, Ekambaram P, Guo Y, Cai Y, Tucker SC, Fridman R, Kandouz M, et al. Platelet-type 12-lipoxygenase induces MMP9 expression and cellular invasion via activation of PI3K/Akt/NF-kappaB. Int J Cancer 2013, 133: 1784-1791.
37. Liu T, Zhou W, Zhang F, Shi G, Teng H, Xiao J, Wang Y. Knockdown of IRX2 inhibits osteosarcoma cell proliferation and invasion by the AKT/MMP9 signaling pathway. Mol Med Rep 2014, 10: 169-174.
38. Borsig L, Wolf MJ, Roblek M, Lorentzen A, Heikenwalder M. Inflammatory chemokines and metastasis - tracing the accessory. Oncogene 2014, 33: 3217-3224.
39. Mueller MM, Fusenig NE. Friends or foes - bipolar effects of the tumour stroma in cancer. Nat Rev Cancer 2004, 4: 839-849.
40. Albulescu R, Codrici E, Popescu ID, Mihai S, Necula LG, Petrescu D, Teodoru M, et al. Cytokine patterns in brain tumour progression. Mediators Inflamm 2013, 2013: 979748.
41. Lazennec G, Richmond A. Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 2010, 16: 133-144.
42. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410: 50-56.
43. Dhami H, Fritz CE, Gankin B, Pak SH, Yi W, Seya MJ, Raffa RB, et al. The chemokine system and CCR5 antagonists: potential in HIV treatment and other novel therapies. J Clin Pharm Ther 2009, 34: 147-160.
44. Douglas SD, Lai JP, Tuluc F, Schwartz L, Kilpatrick LE. Neurokinin-1 receptor expression and function in human macrophages and brain: perspective on the role in HIV neuropathogenesis. Ann NY Acad Sci 2008, 1144: 90-96.
45. Soriano V, Geretti AM, Perno CF, Fatkenheuer G, Pillay D, Reynes J, Tambussi G, et al. Optimal use of maraviroc in clinical practice. AIDS 2008, 22: 2231-2240.
46. Kalev I, Kaasik A, Zarkovski A, Mikelsaar AV. Chemokine receptor CCR5 expression in in vitro differentiating human fetal neural stem/progenitor and glioblastoma cells. Neurosci Lett 2006, 394: 22-27.
47. Kouno J, Nagai H, Nagahata T, Onda M, Yamaguchi H, Adachi K, Takahashi H, et al. Up-regulation of CC chemokine, CCL3L1, and receptors, CCR3, CCR5 in human glioblastoma that promotes cell growth. J Neurooncol 2004, 70: 301-307.
48. Ishii N, Tada M, Sakuma S, Sawamura Y, Shinohe Y, Abe H. Human astrocytoma cells are capable of producing macrophage inflammatory protein-1 beta. J Neurooncol 1998, 37: 17-23.
49. Robinson SC, Scott KA, Wilson JL, Thompson RG, Proudfoot AE, Balkwill FR. A chemokine receptor antagonist inhibits experimental breast tumor growth. Cancer Res 2003, 63: 8360-8365.
50. Yang B, Singh S, Bressani R, Kanmogne GD. Cross-talk between STAT1 and PI3 K/AKT signaling in HIV-1-induced blood-brain barrier dysfunction: role of CCR5 and implications for viral neuropathogenesis. J Neurosci Res 2010, 88: 3090-3101.
51. Kang W, Tong JH, Lung RW, Dong Y, Yang W, Pan Y, Lau KM, et al. let-7b/g silencing activates AKT signaling to promote gastric carcinogenesis. J Transl Med 2014, 12: 281.
52. McCarroll JA, Gan PP, Erlich RB, Liu M, Dwarte T, Sagnella SS, Akerfeldt MC, et al. TUBB3/betaIII-tubulin acts through the PTEN/AKT signaling axis to promote tumorigenesis and anoikis resistance in non-small cell lung cancer. Cancer Res 2015, 75: 415-425.